{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:48:34Z","timestamp":1754153314744,"version":"3.41.2"},"reference-count":62,"publisher":"Georg Thieme Verlag KG","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>The human body has abundant mechanisms to counteract hypoglycemia and prevent neuroglycopenia primarily involving the secretion of glucagon and adrenalin. Within several years from the onset of diabetes, people with type 1 diabetes lose their ability to mount a counterregulatory response to hypoglycemia and develop hypoglycemia unawareness, thus being at risk for deteriorating to a state of severe hypoglycemia and neuroglycopenia. Pregnant individuals with type 1 diabetes are particularly prone to experience severe hypoglycemia during the first half of pregnancy. This may be not only due to the institution of strict glycemic control and the nausea and vomiting prevalent during the early months of pregnancy, but also because the counterregulatory responses are further diminished during pregnancy. Severe hypoglycemia during early pregnancy does not appear to increase the risks of spontaneous abortion or congenital fetal malformations, but the potential long-term effects on the fetus are unknown. Recent technological advances have contributed to improved glycemic control and time in range as well as decreased risk of hypoglycemia in people with diabetes. These advances include treatment with insulin analogs, use of continuous glucose monitors, and closed-loop systems for administration of insulin. Limited studies have demonstrated that pregnant individuals with type 1 diabetes may also benefit from these modalities. While ongoing research continues to explore the adjustment of closed-loop systems for optimal use during pregnancy, more effort is needed to explore the optimal use of these modalities in pregnancy.<\/jats:p>","DOI":"10.1055\/a-2442-7305","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:47:37Z","timestamp":1732733257000},"page":"1381-1388","source":"Crossref","is-referenced-by-count":0,"title":["Hypoglycemia in Pregnant Women with Type 1 Diabetes: Is It Inevitable?"],"prefix":"10.1055","volume":"42","author":[{"given":"Barak M.","family":"Rosenn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Health, Rutgers New Jersey Medical School, Jersey City Medical Center, Jersey City, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane C.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"},{"name":"Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Mimouni","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Research Institute, Leumit Health Services, and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Ehrlich","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"},{"name":"Department of Environmental and Public Health Sciences, University of Cincinnati, College of Medicine, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menachem","family":"Miodovnik","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Inova Health System, Fairfax, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0020-7292(86)90082-2","article-title":"Severe hypoglycemia during pregnancy: its frequency and predisposing factors in diabetic women","volume":"24","author":"W Rayburn","year":"1986","journal-title":"Int J Gynaecol Obstet"},{"issue":"6760","key":"ref2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bmj.301.6760.1070","article-title":"Can prepregnancy care of diabetic women reduce the risk of abnormal babies?","volume":"301","author":"J M Steel","year":"1990","journal-title":"BMJ"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/diacare.15.8.1034","article-title":"Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women","volume":"15","author":"R Kimmerle","year":"1992","journal-title":"Diabetes Care"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1034\/j.1600-0412.2000.079011958.x","article-title":"Prevalence of nocturnal hypoglycemia in first trimester of pregnancy in patients with insulin treated diabetes mellitus","volume":"79","author":"E Hellmuth","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/diacare.25.3.554","article-title":"Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy","volume":"25","author":"I M Evers","year":"2002","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0029-7844(94)00415-A","article-title":"Hypoglycemia: the price of intensive insulin therapy in insulin-dependent diabetes mellitus pregnancies","volume":"85","author":"B Rosenn","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.2337\/dc07-0500","article-title":"Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy","volume":"30","author":"H R Murphy","year":"2007","journal-title":"Diabetes Care"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.AOG.0000129239.82126.a1","article-title":"Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy","volume":"104","author":"Y Yogev","year":"2004","journal-title":"Obstet Gynecol"},{"key":"ref9","first-page":"E67","article-title":"Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction","volume":"260","author":"A Mitrakou","year":"1991","journal-title":"Am J Physiol"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI112884","article-title":"Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms","volume":"79","author":"N S Schwartz","year":"1987","journal-title":"J Clin Invest"},{"key":"ref11","first-page":"526","volume-title":"Hypoglycemia in insulin dependent diabetes mellitus: insulin excess and defective glucose counterregulation","author":"P E Cryer","year":"1990"},{"issue":"09","key":"ref12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198303033080903","article-title":"Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy","volume":"308","author":"N H White","year":"1983","journal-title":"N Engl J Med"},{"issue":"20","key":"ref13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJM198111123052007","article-title":"Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones","volume":"305","author":"G Boden","year":"1981","journal-title":"N Engl J Med"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/diab.32.2.134","article-title":"Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion","volume":"32","author":"G Bolli","year":"1983","journal-title":"Diabetes"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2337\/diab.41.3.255","article-title":"Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle","volume":"41","author":"P E Cryer","year":"1992","journal-title":"Diabetes"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-103-2-184","article-title":"Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes","volume":"103","author":"D C Simonson","year":"1985","journal-title":"Ann Intern Med"},{"issue":"22","key":"ref17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJM198705283162205","article-title":"Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus","volume":"316","author":"S A Amiel","year":"1987","journal-title":"N Engl J Med"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/diab.37.7.901","article-title":"Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release","volume":"37","author":"S A Amiel","year":"1988","journal-title":"Diabetes"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/diab.41.12.1597","article-title":"Intermittent hypoglycemia impairs glucose counterregulation","volume":"41","author":"B Widom","year":"1992","journal-title":"Diabetes"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/jcem-73-5-995","article-title":"Counterregulatory adaptation to recurrent hypoglycemia in normal humans","volume":"73","author":"M R Davis","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9343(91)80085-Z","article-title":"Epidemiology of severe hypoglycemia in the diabetes control and complications trial","volume":"90","author":"Diabetes Control and Complications Trial Research Group","year":"1991","journal-title":"Am J Med"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1152\/ajpendo.00529.2003","article-title":"Pregnancy impairs the counterregulatory response to insulin-induced hypoglycemia in the dog","volume":"287","author":"C C Connolly","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0002-9378(92)91832-U","article-title":"Impairment of counterregulatory hormone responses to hypoglycemia in pregnant women with insulin-dependent diabetes mellitus","volume":"166","author":"M P Diamond","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0029-7844(95)00495-5","article-title":"Counterregulatory hormonal responses to hypoglycemia during pregnancy","volume":"87","author":"B M Rosenn","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2337\/diab.36.12.1372","article-title":"Development of rat embryos cultured in glucose-deficient media","volume":"36","author":"S K Ellington","year":"1987","journal-title":"Diabetes"},{"key":"ref26","first-page":"E269","article-title":"Fuel-mediated teratogenesis: biochemical effects of hypoglycemia during neurulation in mouse embryos in vitro","volume":"257","author":"E S Hunter III","year":"1989","journal-title":"Am J Physiol"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/diab.38.12.1573","article-title":"Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture","volume":"38","author":"M Akazawa","year":"1989","journal-title":"Diabetes"},{"issue":"08","key":"ref28","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/diab.38.8.1063","article-title":"Lack of teratogenic effect of brief maternal insulin-induced hypoglycemia in rats during late neurulation","volume":"38","author":"T A Buchanan","year":"1989","journal-title":"Diabetes"},{"key":"ref29","first-page":"542","article-title":"Electric and insulin shock therapy during pregnancy","volume":"25","author":"D J Impastato","year":"1964","journal-title":"Dis Nerv Syst"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jama.1991.03460060063025","article-title":"Preconception care of diabetes. Glycemic control prevents congenital anomalies","volume":"265","author":"J L Kitzmiller","year":"1991","journal-title":"JAMA"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1056\/NEJM198803173181104","article-title":"Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis","volume":"318","author":"J L Mills","year":"1988","journal-title":"N Engl J Med"},{"key":"ref32","first-page":"247","volume-title":"Hypoglycemia and diabetic pregnancy","author":"J M Steel","year":"1993"},{"key":"ref33","first-page":"66","article-title":"Diabetes in pregnancy: influence of genetic background and maternal diabetic state on the incidence of skeletal malformations in the fetal rat","volume":"277","author":"U J Eriksson","year":"1986","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0020-7292(85)90013-X","article-title":"Fetal heart rate in maternal hypoglycemic coma","volume":"23","author":"E Confino","year":"1985","journal-title":"Int J Gynaecol Obstet"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0301-2115(98)00051-7","article-title":"Fetal heart-rate monitoring during maternal hypoglycaemic coma: a case report","volume":"79","author":"A Matias","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/0002-9378(84)90261-8","article-title":"Persistent fetal bradycardia during maternal hypoglycemia","volume":"149","author":"O Langer","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/00016348309155801","article-title":"Insulin-induced hypoglycemia in pregnant diabetics. Maternal and fetal cardiovascular reactions","volume":"62","author":"M Stangenberg","year":"1983","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-9378(95)90105-1","article-title":"Fetal Doppler and behavioral responses during hypoglycemia induced with the insulin clamp technique in pregnant diabetic women","volume":"172","author":"E A Reece","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"05","key":"ref39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1471-0528.1996.tb09766.x","article-title":"Effects of hypoglycaemia on fetal heart activity and umbilical artery Doppler velocity waveforms in pregnant women with insulin-dependent diabetes mellitus","volume":"103","author":"A O Bj\u00f6rklund","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-999994","article-title":"Increased fetal activity with low maternal blood glucose levels in pregnancies complicated by diabetes","volume":"1","author":"K P Holden","year":"1984","journal-title":"Am J Perinatol"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/diab.46.2.265","article-title":"Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment","volume":"46","author":"J H Anderson Jr","year":"1997","journal-title":"Diabetes"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"g5459","DOI":"10.1136\/bmj.g5459","article-title":"Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis","volume":"349","author":"A C Tricco","year":"2014","journal-title":"BMJ"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1464-5491.2007.02407.x","article-title":"Long-term efficacy and safety of insulin detemir compared to neutral protamine Hagedorn insulin in patients with type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial","volume":"25","author":"P C Bartley","year":"2008","journal-title":"Diabet Med"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc06-1887","article-title":"Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women","volume":"30","author":"E R Mathiesen","year":"2007","journal-title":"Diabetes Care"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc11-2264","article-title":"Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes","volume":"35","author":"E R Mathiesen","year":"2012","journal-title":"Diabetes Care"},{"issue":"S 01","key":"ref46","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.2337\/dc23-S007","article-title":"Diabetes technology: standards of care in diabetes 2023","volume":"46","author":"N A ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"08","key":"ref47","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical standards for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"T Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"D S Feig","year":"2017","journal-title":"Lancet"},{"issue":"05","key":"ref49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1986.03370050073024","article-title":"A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies","volume":"255","author":"D R Coustan","year":"1986","journal-title":"JAMA"},{"issue":"03","key":"ref50","first-page":"121","article-title":"Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy","volume":"12","author":"Q Carta","year":"1986","journal-title":"Diabete Metab"},{"issue":"06","key":"ref51","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1067\/mob.2000.106182","article-title":"Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus","volume":"182","author":"S G Gabbe","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00592-003-0103-1","article-title":"Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy","volume":"40","author":"A Lapolla","year":"2003","journal-title":"Acta Diabetol"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/dia.2021.0073","article-title":"Continuous glucose monitoring time-in-range and HbA1c targets in pregnant women with type 1 diabetes","volume":"23","author":"D Tundidor","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"07","key":"ref54","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","article-title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials","volume":"5","author":"A Weisman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"k1310","DOI":"10.1136\/bmj.k1310","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis","volume":"361","author":"E Bekiari","year":"2018","journal-title":"BMJ"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2337\/dc10-1796","article-title":"Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes","volume":"34","author":"H R Murphy","year":"2011","journal-title":"Diabetes Care"},{"issue":"07","key":"ref57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1602494","article-title":"Closed-loop insulin delivery during pregnancy in women with type 1 diabetes","volume":"375","author":"Z A Stewart","year":"2016","journal-title":"N Engl J Med"},{"issue":"07","key":"ref58","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/dc17-2534","article-title":"Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial","volume":"41","author":"Z A Stewart","year":"2018","journal-title":"Diabetes Care"},{"issue":"03","key":"ref59","doi-asserted-by":"crossref","first-page":"e3248","DOI":"10.1002\/dmrr.3248","article-title":"Case series of a hybrid closed-loop system used in pregnancies in clinical practice","volume":"36","author":"S Polsky","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"07","key":"ref60","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/dia.2021.0521","article-title":"Feasibility of closed-loop insulin delivery with a pregnancy-specific zone model predictive control algorithm","volume":"24","author":"B Ozaslan","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"07","key":"ref61","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/dc23-0173","article-title":"At-home use of a pregnancy-specific zone-MPC closed-loop system for pregnancies complicated by type 1 diabetes: a single-arm observational multicenter study","volume":"46","author":"C J Levy","year":"2023","journal-title":"Diabetes Care"},{"issue":"17","key":"ref62","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMoa2303911","article-title":"Automated insulin delivery in women with pregnancy complicated by type 1 diabetes","volume":"389","author":"T TM Lee","year":"2023","journal-title":"N Engl J Med"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2442-7305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:38:30Z","timestamp":1753223910000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2442-7305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":62,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,7,22]]},"published-print":{"date-parts":[[2025,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2442-7305","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"type":"print","value":"0735-1631"},{"type":"electronic","value":"1098-8785"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}